Z-1017-2025 Class II Ongoing
FDA device recall Z-1017-2025 was initiated by Randox Laboratories, Limited on Dec 20, 2024 and is designated Class II. Reason for recall: Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA. The recall status is ongoing. Affected quantity: 15 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jan 29, 2025
- Initiation Date
- Dec 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15 kits
Product description
Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP3403
Reason for recall
Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.
Distribution pattern
US Nationwide distribution Including PR.
Code information
UDI-DI: 05055273204421 All lots within expiry
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1017-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026